2018
DOI: 10.1158/1538-7445.am2018-4977
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 4977: MIR1307 mediates pancreatic cancer resistance to FOLFIRINOX chemotherapy by affecting response to DNA damage

Abstract: ntroduction: FOLFIRINOX-regime is a combination-chemotherapy that provides the best clinical benefit in pancreatic cancer (PC) patients, but is associated with severe toxicity. Aim of this study is to explore the role of miRNAs (MIR) as modulators of chemosensitivity and their potential as biomarkers of sensitivity to FOLFIRINOX-chemotherapy. Methods: High-throughput-screening (HTS) of 997 LNA-MIR-inhibitors was performed in PC cell lines (Capan1, MiaPaCa2) treated with a combination of Fluorouracil (F), Oxali… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Furthermore, overexpression of miR-1246 results in decreased expression of cyclin-G2 and impairs the cell cycle regulation resulting in resistance to gemcitabine ( 116 ). Recently, miR-1307 was identified to be responsible for FOLFIRINOX resistance in pancreatic cancer ( 120 ). miR-1307 is upregulated in in vitro models of FOLFIRINOX-resistant pancreatic cancer as well as in patient derived material compared to the surrounding tissue ( 120 ).…”
Section: General Principles Of Drug Resistancementioning
confidence: 99%
See 1 more Smart Citation
“…Furthermore, overexpression of miR-1246 results in decreased expression of cyclin-G2 and impairs the cell cycle regulation resulting in resistance to gemcitabine ( 116 ). Recently, miR-1307 was identified to be responsible for FOLFIRINOX resistance in pancreatic cancer ( 120 ). miR-1307 is upregulated in in vitro models of FOLFIRINOX-resistant pancreatic cancer as well as in patient derived material compared to the surrounding tissue ( 120 ).…”
Section: General Principles Of Drug Resistancementioning
confidence: 99%
“…Recently, miR-1307 was identified to be responsible for FOLFIRINOX resistance in pancreatic cancer ( 120 ). miR-1307 is upregulated in in vitro models of FOLFIRINOX-resistant pancreatic cancer as well as in patient derived material compared to the surrounding tissue ( 120 ). Reduced apoptosis rate and an extended acceptance of DNA damage seem to be the consequence of higher miR-1307 expression ( 120 ).…”
Section: General Principles Of Drug Resistancementioning
confidence: 99%